论文部分内容阅读
目的观察苏黄止咳胶囊治疗肺炎咳嗽的效果及对患者C反应蛋白(CRP)水平的影响。方法将54例肺炎咳嗽患者随机分为观察组和对照组各27例。对照组予常规治疗,观察组在对照组基础上加用苏黄止咳胶囊治疗。对比2组临床疗效和治疗前后CRP水平变化。结果观察组治疗总有效率为92.59%高于对照组的70.37%,差异有统计学意义(P<0.05)。治疗前2组血清CRP水平差异无统计学意义(P>0.05)。治疗后,2组CRP水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。结论苏黄止咳胶囊治疗肺炎咳嗽效果显著,CRP改善明显,值得临床推广应用。
Objective To observe the effect of Suhuangzhike Capsule on pneumonia and cough and its effect on the level of C-reactive protein (CRP) in patients. Methods Fifty-four patients with pneumonia and cough were randomly divided into observation group (27 cases) and control group (27 cases). The control group was given routine treatment. The observation group was treated with Suhuangzhike Capsule on the basis of the control group. The clinical efficacy and the changes of CRP levels before and after treatment were compared between the two groups. Results The total effective rate of observation group was 92.59% higher than 70.37% of control group, the difference was statistically significant (P <0.05). There was no significant difference in serum CRP levels between the two groups before treatment (P> 0.05). After treatment, CRP levels in both groups were lower than before treatment, and the observation group was lower than the control group, the difference was statistically significant (P <0.05). Conclusion Suhuangzhike Capsule is effective in treating pneumonia and cough, and the improvement of CRP is obvious. It is worthy of clinical application.